Z Pharmaceuticals, a CNS-focused therapeutic development specialist, today announced the publication of a groundbreaking study in The ...

Z Pharmaceuticals, a CNS-focused therapeutic development specialist, today announced the publication of a groundbreaking study in The Journal ...

Strong evidence for ALS often comes from familial forms of the disease, where specific gene mutations— for example in the ...

Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company dedicated to the discovery and development ...

Leerink Partners Global Healthcare Conference, Miami Wednesday, March 12, 2025 (1x1 meetings) The live and archived webcasts will be accessible from the Company’s website at https://brightmindsbio.com ...

Supernus Pharmaceuticals (NASDAQ:SUPN – Get Free Report) will likely be releasing its earnings data after the market closes ...

Russell Bradley Named President & General Manager of CNSide Dr. Marc Hedrick, Rick Hawkins, and Russell Bradley Join CNSide ...

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by ...

"We’re delighted to welcome Kevin to Avadel – he’s a great addition to our team with the deep experience to help us drive success at this important time," said Greg Divis, Chief Executive Officer of ...

US CNS-focused biopharma firm Axsome Therapeutics today announced that the EMERGE Phase III trial of Symbravo (MoSEIC ...

STOCKHOLM, SWEDEN / ACCESS Newswire / February 24, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR) ), a pharmaceutical company that develops candidate drugs for ...

Grünenthal, a global leader in pain management and related diseases, and Apotex Inc. ("Apotex"), the largest Canadian-based pharmaceutical company, announced today that they have entered into a ...